(Q53516042)

15 May 2018

title

Quality of life associated with diabetes mellitus in an adult population. (English)

1 reference

15 May 2018

1 reference

Brown GC

1

1 reference

15 May 2018

Brown MM

2

1 reference

15 May 2018

Sharma S

3

1 reference

15 May 2018

Brown H

4

1 reference

15 May 2018

Gozum M

5

1 reference

15 May 2018

Denton P

6

1 reference

15 May 2018

publication date

1 January 2000

1 reference

15 May 2018

Journal of Diabetes and its Complications

published in

1 reference

15 May 2018

volume

14

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

18-24

1 reference

15 May 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Utility values and diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Cost-effectiveness of treatment for threshold retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Evidence-based medicine, utilities, and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Quality of life in NIDDM patients assessed with the SF-20 questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Cost-Effectiveness of Screening for Carotid Stenosis in Asymptomatic Persons

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Valuing quality of life and improvements in glycemic control in people with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Utilities and quality-adjusted life years

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900061-1

7 January 2021

10.1016/S1056-8727(00)00061-1

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018